Mizuho Securities analyst Irina Rivkind Koffler was out today with research notes on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Relypsa Inc (NASDAQ:RLYP). The analyst …
Merrimack Pharmaceuticals Inc Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares closed down over 6% Friday, after the cancer drug maker reported second-quarter results, with net Onivyde sales …
In a research note issued this morning, Cantor analyst Mara Goldstein reiterated a Hold rating on shares of Relypsa Inc (NASDAQ:RLYP) with a price …
In wake of Galenica buying out Relypsa Inc (NASDAQ:RLYP) for a $1.53 billion deal of $32 per share, Cantor analyst Mara Goldstein has …
New insights emerge in the biotech sector as Valeant Pharmaceuticals Intl Inc (NYSE:VRX) received a Complete Response Letter (CRL) from the FDA on its eye …
Relypsa Inc Yesterday, Relypsa Inc (NASDAQ:RLYP) announced that Galenica and Relypsa have entered into a definitive agreement under which Galenica will acquire Relypsa. …
Galenica AG, specialty pharma giant owning Switzerland’s largest pharmacy network, is set to add drug-maker Relypsa Inc (NASDAQ:RLYP) to its beefed-up network, gaining …
Wedbush analyst Liana Moussatos weighs in on Relypsa Inc (NASDAQ:RLYP), following the news that Switzerland’s Galenica Group has agreed to buy Relypsa for $32 …
Shares of Relypsa Inc (NASDAQ:RLYP) jumped 59% to $32 in pre-market trading, after the company announced that it is going to be acquired by …
Analyst Difei Yang of Brean Capital feels reassured about the Relypsa Inc’s (NASDAQ:RLYP) ascending success, calling attention to its up-and-coming potassium-binding Valtassa, a beta …